FACTANKER · measured, cited, anchored official records connected

GILEAD SCIENCES, INC. — Operating Income by Fiscal Year

19 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/530b851b-6376-460a-b3ec-670a89cf68c4/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$10.0B2025-01-01 – 2025-12-31evidence 0000882095-26-000006
FY 2024$1.7B2024-01-01 – 2024-12-31evidence 0000882095-25-000006
FY 2023$7.6B2023-01-01 – 2023-12-31evidence 0000882095-24-000007
FY 2022$7.3B2022-01-01 – 2022-12-31evidence 0000882095-23-000007
FY 2021$9.9B2021-01-01 – 2021-12-31evidence 0000882095-22-000007
FY 2020$4.1B2020-01-01 – 2020-12-31evidence 0000882095-21-000008
FY 2019$4.3B2019-01-01 – 2019-12-31evidence 0000882095-20-000006
FY 2018$8.2B2018-01-01 – 2018-12-31evidence 0000882095-19-000006
FY 2017$14.1B2017-01-01 – 2017-12-31evidence 0000882095-18-000008
FY 2016$17.6B2016-01-01 – 2016-12-31evidence 0000882095-17-000006
FY 2015$22.2B2015-01-01 – 2015-12-31evidence 0000882095-16-000039
FY 2014$15.3B2014-01-01 – 2014-12-31evidence 0000882095-15-000008
FY 2013$4.5B2013-01-01 – 2013-12-31evidence 0000882095-15-000008
FY 2012$4.0B2012-01-01 – 2012-12-31evidence 0000882095-15-000008
FY 2011$3.8B2011-01-01 – 2011-12-31evidence 0001193125-12-075335
FY 2010$4.0B2010-01-01 – 2010-12-31evidence 0001193125-11-050041
FY 2009$3.5B2009-01-01 – 2009-12-31evidence 0001193125-10-044753
FY 2008$2.7B2008-01-01 – 2008-12-31evidence 0001193125-10-044753
FY 2007$2.2B2007-01-01 – 2007-12-31evidence 0001193125-10-044753
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

GILEAD SCIENCES, INC. — all facts · Revenue · Net Income